# Ionis Pharmaceuticals, Inc. Common Stock (IONS)

Ionis Pharmaceuticals' partner GSK announced positive Phase [--] results for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B. The stock has also hit a 52-week high, driven by strong Q3 earnings and promising trial data.

### About Ionis Pharmaceuticals, Inc. Common Stock
Ionis Pharmaceuticals, Inc. is a biotechnology company focused on developing RNA-targeted therapeutics.  
Ionis Pharmaceuticals, Inc. Common Stock uses the ticker $IONS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Ionis Pharmaceuticals, Inc. Common Stock (IONS) posts created is up 16% from the previous week.

### Price: $80.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ions/time-series/close.tsv)  
The stock price is experiencing a significant surge, hitting a 52-week high, driven by positive analyst sentiment, strong Q3 earnings, and promising Phase [--] trial results for key drugs, supported by increased trading volume and social media engagement.  

24-Hour: -1.44%
7-Day: -4.98%
30-Day: 5.59%

1-Year High: $86.50 on 2026-02-06  
1-Year Low: $25.50 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ions/time-series/alt_rank.tsv)  
Ionis Pharmaceuticals, Inc. Common Stock (IONS) is currently AltRank #1,383 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +831  
[--] Month: [-----] +857  
[--] Months: [-----] +1,263  
[--] Year: [-----] +917  
1-Year High: [-----] on 2025-03-09  
1-Year Low: [--] on 2025-07-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ions/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +1  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-04-07  
1-Year Low: [--] on 2026-01-08  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ions/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] -43%  
[--] Month: [-------] -66%  
[--] Months: [---------] +2.40%  
[--] Year: [---------] +88%  
1-Year High: [-------] on 2025-02-19  
1-Year Low: [-----] on 2025-03-09  

Engagements by network (24h):
News: [--]
TikTok: [---]
Reddit: [--]
YouTube: [--]
X: [-----]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ions/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] -2%  
[--] Month: [---] -3.30%  
[--] Months: [-----] +23%  
[--] Year: [-----] +106%  
1-Year High: [---] on 2025-11-23  
1-Year Low: [--] on 2025-03-06  

Mentions by network (24h):
News: [--]
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ions/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Ionis Pharmaceuticals, Inc. Common Stock (IONS) in the last [--] hours which is down 4.40% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +2.10%  
[--] Month: [---] -7.60%  
[--] Months: [-----] -19%  
[--] Year: [-----] +133%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-02-16  

The most influential creators that mention Ionis Pharmaceuticals, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@StarCatBloomTH](/creator/twitter/StarCatBloomTH)   | [--]    | [------]    | [--]     | [-----]       |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [---]         |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | [--]    | [---]       | [--]     | [--]          |
| [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS)     | [--]    | [---]       | [--]     | [--]          |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | [--]    | [------]    | [--]     | [--]          |
| [@BehaviorFin](/creator/twitter/BehaviorFin)         | [--]    | [-----]     | [--]     | [--]          |
| [@HedgeFundTips](/creator/twitter/HedgeFundTips)     | [--]    | [------]    | [--]     | [--]          |
| [@StockMKTNewz](/creator/twitter/StockMKTNewz)       | [--]    | [-------]   | [--]     | [--]          |
| [@avinash_redekar](/creator/twitter/avinash_redekar) | [--]    | [------]    | [--]     | [--]           |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | [--]   | [-----]     | [--]     | [--]           |

[View More](/list/creators/$ions/100)
  
  
### Sentiment: 80%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ions/time-series/sentiment.tsv)  
Current Value: 80%  
Daily Average: 78%  
[--] Week: 33% -45%  
[--] Month: 81% -8%  
[--] Months: 81% -7%  
[--] Year: 81% +23%  
1-Year High: 100% on 2025-03-09  
1-Year Low: 38% on 2025-02-26  

Most Supportive Themes:
- Analyst Upgrades and Price Targets: (30%) Analysts are increasing their confidence and price targets for Ionis Pharmaceuticals.
- Positive Phase [--] Trial Results: (25%) Promising results from Phase [--] trials for olezarsen and zilganersen are leading to planned regulatory filings.
- Strong Q3 Earnings Report: (20%) Ionis Pharmaceuticals reported strong Q3 earnings, exceeding expectations and raising its full-year revenue outlook.
- 52-Week High Stock Price: (15%) The stock has reached a 52-week high, reflecting positive market sentiment and strong community engagement.
  
Most Critical Themes:
- FDA Holds on Drug Testing: (5%) The FDA has placed a hold on certain drug testing, which could potentially delay study readouts and impact investor sentiment.
  
  
  
### Social Dominance: 0.00432%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ions/time-series/social_dominance.tsv)  
Current Value: 0.00432%  
Daily Average: 0.016%  
[--] Week: 0.0059% +0.00010000000000000026%  
[--] Month: 0.0063% -0.0068%  
[--] Months: 0.0063% -0.013%  
[--] Year: 0.0063% -0.017%  
1-Year High: 0.053% on 2025-09-03  
1-Year Low: 0.0061% on 2026-02-13  
  
  
### Market Dominance: 0.015%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ions/time-series/market_dominance.tsv)  
Current Value: 0.015%  
Daily Average: 0%  
1-Year High: 0.18% on 2025-03-31  
1-Year Low: 0.00669% on 2025-04-10  
  
  
### Market Cap: $13,055,136,076
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ions/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ions/time-series/market_cap.tsv)  
Current Value: $13,055,136,076  
Daily Average: $8,777,349,200  
[--] Week: $13,055,136,076 -7.10%  
[--] Month: $13,055,136,076 +4.40%  
[--] Months: $13,055,136,076 +89%  
[--] Year: $13,055,136,076 +165%  
1-Year High: $14,010,784,995 on 2026-02-06  
1-Year Low: $4,055,191,334 on 2025-04-08  

### Top Ionis Pharmaceuticals, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"I've been looking forward to this for a long time. A friend gave me this game today. A very quick doodle. 😭💓 #Reanimal"  
[X Link](https://x.com/StarCatBloomTH/status/2022430816689869264) [@StarCatBloomTH](/creator/x/StarCatBloomTH) 2026-02-13T22:00Z 19K followers, [----] engagements


"📍 KOCHI $E$$IONS available Feb [----] DM for details. #FEET #feet_pic #FINDOM4EVER #findom @Goddess_Emy2304 @rt_feet @FemdomWorld_PR @DommeDaily @FemdomDaily @FinDommes @ArunDev14435975"  
[X Link](https://x.com/Goddess_Emy2304/status/2021659049952153939) [@Goddess_Emy2304](/creator/x/Goddess_Emy2304) 2026-02-11T18:54Z [---] followers, [----] engagements


"Updated timestamp to include additional psychedelics ( $GHRS $ATAI etc) $STVN (as of Feb 3) additional $QURE. $IONS with a brand new high as of today. +100.1% from May [--] start date. Hypothetical return of an uncapped $100k portfolio that purchased every timestamped post on the blog since launch; +87.9%. Names like $TWST will carry greater weighting due to less binary risk conviction and compounding nature. Obviously subject to changes in allocation. https://t.co/bq7Q6iTt2q Hypothetical return of an uncapped $100k portfolio that purchased every timestamped post on the blog since launch;"  
[X Link](https://x.com/peter_mantas/status/2019989811210428927) [@peter_mantas](/creator/x/peter_mantas) 2026-02-07T04:21Z [----] followers, [----] engagements


"Ionis partner GSK announces positive topline results from B-Well [--] and B-Well [--] Phase [--] studies for bepirovirsen a potential first-in-class medicine for chronic hepatitis B Ionis Pharmaceuticals Inc. https://ir.ionis.com/news-releases/news-release-details/ionis-partner-gsk-announces-positive-topline-results-b-well-1"  
[TikTok Link](https://www.tiktok.com/@carsonkleppe/video/7592684591102610743) [@carsonkleppe](/creator/tiktok/carsonkleppe) 2026-01-07T18:14Z [---] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing